Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of Pseudomonas aeruginosa treated with hydrogen peroxide
Background: Pseudomonas aeruginosa, a pathogen infecting those with cystic fibrosis, encounters toxicity from phagocyte-derived reactive oxidants including hydrogen peroxide during active infection. P. aeruginosa responds with adaptive and protective strategies against these toxic species to effect...
ORGANISM(S): Pseudomonas aeruginosa 
2007-07-19 | E-GEOD-3090 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of Pseudomonas aeruginosa response to odium hypochlorite antimicrobial mechanisms
In the present study, we employed Affymetrix Pseudomonas aeruginosa GeneChip arrays to investigate global gene expression profiles during the cellular response of Pseudomonas aeruginosa to sodium hypochlorite Experiment Overall Design: We calculated fold change as the ratio between the signal averag...
ORGANISM(S): Pseudomonas aeruginosa 
2008-06-15 | E-GEOD-7402 | biostudies-arrayexpress
UnknownApplication of human umbilical cord blood-derived mesenchymal stem cells in disease models.
Not available
S-EPMC3097922 | biostudies-literature
TranscriptomicsEscherichia coli K-12: luxS mutant LW12 vs. wild type W3110
Transcripitonal profiling of Escherichia coli K-12 comparing luxS mutant LW12 with wild type W3110 One-condition experiment, luxS mutant LW12 vs. wild type W3110
ORGANISM(S): Escherichia coli 
2010-11-11 | E-GEOD-20606 | biostudies-arrayexpress
TranscriptomicsEscherichia coli K-12: luxS mutant LW12 vs. wild type W3110 under H2O2 stress
Transcriptional profiling of Escherichia coli K-12 comparing luxS mutant LW12 with wild type W3110 exposure to 10mM or 30mM hydrogen peroxide. Two-condition experiment, luxS mutant LW12 vs. wild type W3110, treatment with 10mM hydrogen peroxide for 30min or treatment with 30mM hydrogen peroxide for ...
ORGANISM(S): Escherichia coli 
2014-05-08 | E-GEOD-16335 | biostudies-arrayexpress
UnknownThe ENCODE Imputation Challenge: a critical assessment of methods for cross-cell type imputation of epigenomic profiles.
Not available
S-EPMC10111747 | biostudies-literature
UnknownRivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
Not available
S-EPMC6662613 | biostudies-literature
Sort   by:  
 Page size